These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22391976)

  • 1. Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
    Nölting S; Grossman AB
    Endocr Pathol; 2012 Mar; 23(1):21-33. PubMed ID: 22391976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers of paragangliomas/pheochromocytomas.
    Zhikrivetskaya SO; Snezhkina AV; Zaretsky AR; Alekseev BY; Pokrovsky AV; Golovyuk AL; Melnikova NV; Stepanov OA; Kalinin DV; Moskalev AA; Krasnov GS; Dmitriev AA; Kudryavtseva AV
    Oncotarget; 2017 Apr; 8(15):25756-25782. PubMed ID: 28187001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.
    Santarpia L; Habra MA; Jiménez C
    Horm Metab Res; 2009 Sep; 41(9):680-6. PubMed ID: 19343618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
    Yao L; Schiavi F; Cascon A; Qin Y; Inglada-Pérez L; King EE; Toledo RA; Ercolino T; Rapizzi E; Ricketts CJ; Mori L; Giacchè M; Mendola A; Taschin E; Boaretto F; Loli P; Iacobone M; Rossi GP; Biondi B; Lima-Junior JV; Kater CE; Bex M; Vikkula M; Grossman AB; Gruber SB; Barontini M; Persu A; Castellano M; Toledo SP; Maher ER; Mannelli M; Opocher G; Robledo M; Dahia PL
    JAMA; 2010 Dec; 304(23):2611-9. PubMed ID: 21156949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas.
    Oudijk L; Papathomas T; de Krijger R; Korpershoek E; Gimenez-Roqueplo AP; Favier J; Canu L; Mannelli M; Rapa I; Currás-Freixes M; Robledo M; Smid M; Papotti M; Volante M
    Neuroendocrinology; 2017; 105(4):384-393. PubMed ID: 28122379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.
    Favier J; Igaz P; Burnichon N; Amar L; Libé R; Badoual C; Tissier F; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
    Endocr Pathol; 2012 Mar; 23(1):34-42. PubMed ID: 22183643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy and metabolic alterations in predisposition to pheochromocytomas and paragangliomas: the so-called Warburg (and more) effect, 15 years on.
    Neumann HP; de Herder W
    Endocr Relat Cancer; 2015 Aug; 22(4):E5-7. PubMed ID: 26273100
    [No Abstract]   [Full Text] [Related]  

  • 8. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
    Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach.
    Sarkadi B; Saskoi E; Butz H; Patocs A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
    Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Landscape of Pheochromocytoma and Paraganglioma.
    Jochmanova I; Pacak K
    Trends Cancer; 2018 Jan; 4(1):6-9. PubMed ID: 29413423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of pheochromocytomas and paragangliomas.
    Opocher G; Schiavi F
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
    Korpershoek E; Favier J; Gaal J; Burnichon N; van Gessel B; Oudijk L; Badoual C; Gadessaud N; Venisse A; Bayley JP; van Dooren MF; de Herder WW; Tissier F; Plouin PF; van Nederveen FH; Dinjens WN; Gimenez-Roqueplo AP; de Krijger RR
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1472-6. PubMed ID: 21752896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of pheochromocytoma and paraganglioma.
    Wachtel H; Fishbein L
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):283-290. PubMed ID: 33764930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practice.
    Varghese J; Skefos CM; Jimenez C
    Mol Cell Endocrinol; 2024 Oct; 592():112344. PubMed ID: 39182716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the genetics of paragangliomas.
    Gimenez-Roqueplo AP; Robledo M; Dahia PLM
    Endocr Relat Cancer; 2023 Apr; 30(4):. PubMed ID: 36748842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma: Gasping for Air.
    Jochmanová I; Zhuang Z; Pacak K
    Horm Cancer; 2015 Dec; 6(5-6):191-205. PubMed ID: 26138106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.
    Burnichon N; Vescovo L; Amar L; Libé R; de Reynies A; Venisse A; Jouanno E; Laurendeau I; Parfait B; Bertherat J; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2011 Oct; 20(20):3974-85. PubMed ID: 21784903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.
    Loriot C; Burnichon N; Gadessaud N; Vescovo L; Amar L; Libé R; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP; Favier J
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E954-62. PubMed ID: 22492777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.